Cargando...
Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD
Inhaled fixed-dose combinations (FDCs) of a long-acting β-agonist (LABA) and a long-acting muscarinic antagonist (LAMA) have become the cornerstone for the maintenance treatment of symptomatic COPD patients. In this regard, global COPD treatment guidelines have recognized the importance of inhaler d...
Gardado en:
| Publicado en: | Pulm Ther |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer Healthcare
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6967354/ https://ncbi.nlm.nih.gov/pubmed/32026426 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41030-019-0090-1 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|